Orellanine specifically targets renal clear cell carcinoma

Renal cell carcinoma (RCC), arising from the proximal tubule in the kidney, accounts for approximately 85% of kidney cancers and causes over 140,000 annual deaths worldwide. In the last decade, several new therapies have been identified for treatment of metastatic RCC. Although these therapies incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Buvall, Lisa, Hedman, Heidi, Khramova, Alina, Najar, Deman, Bergwall, Lovisa, Ebefors, Kerstin, Sihlbom, Carina, Lundstam, Sven, Herrmann, Anders, Wallentin, Hanna, Roos, Emelie, Nilsson, Ulf A., Johansson, Martin, Törnell, Jan, Haraldsson, Börje, Nyström, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710908/
https://www.ncbi.nlm.nih.gov/pubmed/29207627
http://dx.doi.org/10.18632/oncotarget.19555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710908/
https://www.ncbi.nlm.nih.gov/pubmed/29207627
http://dx.doi.org/10.18632/oncotarget.19555

Ejemplares similares